News SanBio Company Limited OTC Markets

Equities

SNBOY

US7995731004

Market Closed - OTC Markets Other stock markets 19:09:17 09/04/2024 BST			5-day change	1st Jan Change
2.81 ^USD	-48.72%		-.--%	-.--%

03-19	SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	MT
03-19	Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	03-19	MT
Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	03-19	MT
Transcript : SanBio Company Limited, 2024 Earnings Call, Mar 19, 2024	03-19
SanBio Books Non-operating Income, Extraordinary Gains, Deferred Income Taxes in Fiscal 2024	03-19	MT
SanBio's FY2024 Attributable Net Loss Narrows on Lower Costs, Forex Gains	03-19	MT
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2025, and Full Fiscal Year Ending January 31, 2025	03-18	CI
SanBio Liquidates Singapore Unit	02-14	MT
Sanbio Co., Ltd. Provides Update on Status of Manufacturing and Marketing Approval for Sb623 Chronic Traumatic Brain Injury Program in Japan	01-25	CI
SanBio to Cancel Certain Stock Options	01-10	MT
SanBio Logs Extraordinary Gain from Asset Sale of US Unit	12-21	MT
Sanbio Widens Nine-Month Attributable Net Loss	12-15	MT
Sanbio Cuts Staff Amid Restructuring of Overseas Subsidiary	12-15	MT
Sanbio Expects to Receive Regulatory Nod for Stem Cell Therapy Candidate in March 2024	12-15	MT
SanBio Company Limited Provides Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	12-14	CI
Jefferies Adjusts Sanbio’ Price Target to 310 Yen From 420 Yen, Keeps at Underperform	25/10/23	MT
Transcript : SanBio Company Limited, Q2 2024 Earnings Call, Sep 15, 2023	15/09/23
Jefferies Adjusts SanBio's Price Target to 420 Yen From 550 Yen, Keeps at Underperform	28/07/23	MT
SanBio's Overseas Subsidiary to Carry Out Personnel Reduction by November	12/07/23	MT
SanBio Co., Ltd. Updates on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14/06/23	CI
SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half and Full Year Ending January 31, 2024	14/06/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SanBio Company Limited OTC Markets

Equities

SNBOY

US7995731004

Summary

Filters